Titre : Sérogroupe

Sérogroupe : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment identifier un sérogroupe spécifique ?

Par des tests sérologiques qui détectent des anticorps spécifiques.
Sérologie Anticorps
#2

Quels tests sont utilisés pour le diagnostic ?

Les tests ELISA et l'immunofluorescence sont couramment utilisés.
Test ELISA Immunofluorescence
#3

Peut-on diagnostiquer par culture ?

Oui, la culture de microorganismes peut aider à identifier le sérogroupe.
Culture bactérienne Identification des microorganismes
#4

Les tests PCR sont-ils utiles ?

Oui, la PCR peut détecter des séquences spécifiques de l'ADN des microorganismes.
PCR Détection des agents pathogènes
#5

Quel rôle joue l'historique médical ?

L'historique aide à orienter les tests et à identifier les sérogroupes possibles.
Historique médical Évaluation clinique

Symptômes 5

#1

Quels symptômes sont associés aux infections par sérogroupe ?

Les symptômes varient, mais incluent fièvre, douleurs et inflammation.
Symptômes Infection
#2

Les symptômes varient selon le sérogroupe ?

Oui, chaque sérogroupe peut provoquer des symptômes spécifiques.
Variabilité des symptômes Sérogroupe
#3

Y a-t-il des symptômes communs ?

Des symptômes comme la fatigue et la fièvre sont souvent communs.
Fatigue Fièvre
#4

Les symptômes peuvent-ils être graves ?

Oui, certains sérogroupes peuvent entraîner des complications graves.
Complications Gravité des symptômes
#5

Comment les symptômes évoluent-ils ?

Ils peuvent s'aggraver rapidement sans traitement approprié.
Évolution des symptômes Traitement

Prévention 5

#1

Comment prévenir les infections par sérogroupe ?

Par la vaccination, l'hygiène et l'évitement des contacts à risque.
Prévention des infections Hygiène
#2

Les vaccins sont-ils efficaces ?

Oui, les vaccins peuvent réduire significativement le risque d'infection.
Efficacité des vaccins Prévention
#3

Quelles mesures d'hygiène sont recommandées ?

Se laver les mains régulièrement et éviter les contacts avec des malades.
Hygiène Prévention des infections
#4

Les voyages augmentent-ils le risque ?

Oui, voyager dans des zones à risque peut augmenter l'exposition aux sérogroupes.
Voyages Exposition aux infections
#5

Les comportements à risque à éviter ?

Éviter les foules et les contacts étroits avec des personnes malades.
Comportements à risque Prévention

Traitements 5

#1

Quels traitements sont disponibles pour les infections ?

Les antibiotiques ou antiviraux sont souvent utilisés selon le sérogroupe.
Antibiotiques Antiviraux
#2

Les traitements varient-ils selon le sérogroupe ?

Oui, chaque sérogroupe peut nécessiter un traitement spécifique.
Traitement spécifique Sérogroupe
#3

Les vaccins sont-ils disponibles ?

Oui, certains sérogroupes ont des vaccins pour prévenir les infections.
Vaccins Prévention des infections
#4

Comment évaluer l'efficacité du traitement ?

Par le suivi des symptômes et des tests sérologiques après traitement.
Suivi médical Efficacité du traitement
#5

Y a-t-il des traitements alternatifs ?

Des traitements complémentaires peuvent être envisagés, mais doivent être validés.
Médecine complémentaire Traitements alternatifs

Complications 5

#1

Quelles complications peuvent survenir ?

Des complications comme la septicémie ou des infections localisées peuvent survenir.
Septicémie Complications infectieuses
#2

Les complications varient-elles selon le sérogroupe ?

Oui, chaque sérogroupe peut entraîner des complications spécifiques.
Complications Sérogroupe
#3

Comment prévenir les complications ?

Un traitement précoce et approprié peut réduire le risque de complications.
Prévention des complications Traitement précoce
#4

Les complications peuvent-elles être mortelles ?

Oui, certaines complications peuvent être graves et potentiellement mortelles.
Complications graves Mortalité
#5

Quels signes indiquent des complications ?

Des signes comme une aggravation des symptômes ou une nouvelle fièvre doivent alerter.
Signes d'alerte Complications

Facteurs de risque 5

#1

Quels sont les facteurs de risque d'infection ?

Les facteurs incluent l'âge, l'immunodépression et les conditions de vie.
Facteurs de risque Immunodépression
#2

Les antécédents médicaux influencent-ils le risque ?

Oui, des antécédents d'infections augmentent le risque de réinfection.
Antécédents médicaux Risque d'infection
#3

Le mode de vie joue-t-il un rôle ?

Oui, un mode de vie sain peut réduire le risque d'infection.
Mode de vie Prévention des infections
#4

Les voyages à l'étranger augmentent-ils le risque ?

Oui, voyager dans des zones endémiques expose à des sérogroupes spécifiques.
Voyages Exposition aux infections
#5

Les conditions environnementales influencent-elles le risque ?

Oui, des conditions comme la pollution ou le surpeuplement peuvent augmenter le risque.
Conditions environnementales Risque d'infection
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sérogroupe : Questions médicales les plus fréquentes", "headline": "Sérogroupe : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sérogroupe : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-30", "dateModified": "2025-04-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sérogroupe" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Phénotype", "url": "https://questionsmedicales.fr/mesh/D010641", "about": { "@type": "MedicalCondition", "name": "Phénotype", "code": { "@type": "MedicalCode", "code": "D010641", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.695" } } }, "about": { "@type": "MedicalCondition", "name": "Sérogroupe", "alternateName": "Serogroup", "code": { "@type": "MedicalCode", "code": "D065288", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ray Borrow", "url": "https://questionsmedicales.fr/author/Ray%20Borrow", "affiliation": { "@type": "Organization", "name": "Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom." } }, { "@type": "Person", "name": "Bo Pang", "url": "https://questionsmedicales.fr/author/Bo%20Pang", "affiliation": { "@type": "Organization", "name": "State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. pangbo@icdc.cn." } }, { "@type": "Person", "name": "Biao Kan", "url": "https://questionsmedicales.fr/author/Biao%20Kan", "affiliation": { "@type": "Organization", "name": "State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. kanbiao@icdc.cn." } }, { "@type": "Person", "name": "Lucy A McNamara", "url": "https://questionsmedicales.fr/author/Lucy%20A%20McNamara", "affiliation": { "@type": "Organization", "name": "Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, USA." } }, { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A case-control study of infections caused by", "datePublished": "2022-07-28", "url": "https://questionsmedicales.fr/article/35967868", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fcimb.2022.867347" } }, { "@type": "ScholarlyArticle", "name": "Errors in Surgery: A Case Control Study.", "datePublished": "2022-08-10", "url": "https://questionsmedicales.fr/article/35946794", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/SLA.0000000000005664" } }, { "@type": "ScholarlyArticle", "name": "Iron status in women with infertility and controls: a case-control study.", "datePublished": "2023-06-08", "url": "https://questionsmedicales.fr/article/37361544", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fendo.2023.1173100" } }, { "@type": "ScholarlyArticle", "name": "Sleeve Gastrectomy in Septuagenarians: a Case-Control Study.", "datePublished": "2022-07-05", "url": "https://questionsmedicales.fr/article/35788952", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11695-022-06193-8" } }, { "@type": "ScholarlyArticle", "name": "Diverticulitis Familiality: A Statewide Case-Control Study.", "datePublished": "2023-07-05", "url": "https://questionsmedicales.fr/article/37403933", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/XCS.0000000000000799" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Phénotype", "item": "https://questionsmedicales.fr/mesh/D010641" }, { "@type": "ListItem", "position": 4, "name": "Sérogroupe", "item": "https://questionsmedicales.fr/mesh/D065288" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sérogroupe - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sérogroupe", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sérogroupe", "description": "Comment identifier un sérogroupe spécifique ?\nQuels tests sont utilisés pour le diagnostic ?\nPeut-on diagnostiquer par culture ?\nLes tests PCR sont-ils utiles ?\nQuel rôle joue l'historique médical ?", "url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Case-Control+Studies#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sérogroupe", "description": "Quels symptômes sont associés aux infections par sérogroupe ?\nLes symptômes varient selon le sérogroupe ?\nY a-t-il des symptômes communs ?\nLes symptômes peuvent-ils être graves ?\nComment les symptômes évoluent-ils ?", "url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Case-Control+Studies#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sérogroupe", "description": "Comment prévenir les infections par sérogroupe ?\nLes vaccins sont-ils efficaces ?\nQuelles mesures d'hygiène sont recommandées ?\nLes voyages augmentent-ils le risque ?\nLes comportements à risque à éviter ?", "url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Case-Control+Studies#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sérogroupe", "description": "Quels traitements sont disponibles pour les infections ?\nLes traitements varient-ils selon le sérogroupe ?\nLes vaccins sont-ils disponibles ?\nComment évaluer l'efficacité du traitement ?\nY a-t-il des traitements alternatifs ?", "url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Case-Control+Studies#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sérogroupe", "description": "Quelles complications peuvent survenir ?\nLes complications varient-elles selon le sérogroupe ?\nComment prévenir les complications ?\nLes complications peuvent-elles être mortelles ?\nQuels signes indiquent des complications ?", "url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Case-Control+Studies#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sérogroupe", "description": "Quels sont les facteurs de risque d'infection ?\nLes antécédents médicaux influencent-ils le risque ?\nLe mode de vie joue-t-il un rôle ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes conditions environnementales influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D065288?mesh_terms=Case-Control+Studies#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un sérogroupe spécifique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Par des tests sérologiques qui détectent des anticorps spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests ELISA et l'immunofluorescence sont couramment utilisés." } }, { "@type": "Question", "name": "Peut-on diagnostiquer par culture ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la culture de microorganismes peut aider à identifier le sérogroupe." } }, { "@type": "Question", "name": "Les tests PCR sont-ils utiles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la PCR peut détecter des séquences spécifiques de l'ADN des microorganismes." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique aide à orienter les tests et à identifier les sérogroupes possibles." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux infections par sérogroupe ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes varient, mais incluent fièvre, douleurs et inflammation." } }, { "@type": "Question", "name": "Les symptômes varient selon le sérogroupe ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque sérogroupe peut provoquer des symptômes spécifiques." } }, { "@type": "Question", "name": "Y a-t-il des symptômes communs ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue et la fièvre sont souvent communs." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils être graves ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains sérogroupes peuvent entraîner des complications graves." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent s'aggraver rapidement sans traitement approprié." } }, { "@type": "Question", "name": "Comment prévenir les infections par sérogroupe ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Par la vaccination, l'hygiène et l'évitement des contacts à risque." } }, { "@type": "Question", "name": "Les vaccins sont-ils efficaces ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccins peuvent réduire significativement le risque d'infection." } }, { "@type": "Question", "name": "Quelles mesures d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et éviter les contacts avec des malades." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones à risque peut augmenter l'exposition aux sérogroupes." } }, { "@type": "Question", "name": "Les comportements à risque à éviter ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les foules et les contacts étroits avec des personnes malades." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les infections ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques ou antiviraux sont souvent utilisés selon le sérogroupe." } }, { "@type": "Question", "name": "Les traitements varient-ils selon le sérogroupe ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque sérogroupe peut nécessiter un traitement spécifique." } }, { "@type": "Question", "name": "Les vaccins sont-ils disponibles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains sérogroupes ont des vaccins pour prévenir les infections." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité du traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Par le suivi des symptômes et des tests sérologiques après traitement." } }, { "@type": "Question", "name": "Y a-t-il des traitements alternatifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements complémentaires peuvent être envisagés, mais doivent être validés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme la septicémie ou des infections localisées peuvent survenir." } }, { "@type": "Question", "name": "Les complications varient-elles selon le sérogroupe ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque sérogroupe peut entraîner des complications spécifiques." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Un traitement précoce et approprié peut réduire le risque de complications." } }, { "@type": "Question", "name": "Les complications peuvent-elles être mortelles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent être graves et potentiellement mortelles." } }, { "@type": "Question", "name": "Quels signes indiquent des complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme une aggravation des symptômes ou une nouvelle fièvre doivent alerter." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'infection ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, l'immunodépression et les conditions de vie." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents d'infections augmentent le risque de réinfection." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain peut réduire le risque d'infection." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones endémiques expose à des sérogroupes spécifiques." } }, { "@type": "Question", "name": "Les conditions environnementales influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme la pollution ou le surpeuplement peuvent augmenter le risque." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 26/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Ray Borrow

6 publications dans cette catégorie

Affiliations :
  • Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
  • University of Manchester, Infection, Immunity & Respiratory Medicine, School of Biological Sciences, Stopford Building, Manchester, United Kingdom.
Publications dans "Sérogroupe" : Voir toutes les publications (6)

Bo Pang

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. pangbo@icdc.cn.
  • Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China. pangbo@icdc.cn.
Publications dans "Sérogroupe" :

Biao Kan

3 publications dans cette catégorie

Affiliations :
  • State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. kanbiao@icdc.cn.
  • Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China. kanbiao@icdc.cn.
Publications dans "Sérogroupe" :

Lucy A McNamara

3 publications dans cette catégorie

Affiliations :
  • Meningitis and Vaccine Preventable Diseases Branch, Centers for Disease Control and Prevention, Atlanta, USA.

Raquel Abad

3 publications dans cette catégorie

Affiliations :
  • National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
Publications dans "Sérogroupe" :

Amit Srivastava

3 publications dans cette catégorie

Affiliations :
  • Vaccine Medical Development, Scientific & Clinical Affairs, Pfizer Inc, Collegeville, PA, USA.

Muhamed-Kheir Taha

3 publications dans cette catégorie

Affiliations :
  • Institut Pasteur, Invasive bacterial infections Unit and National Reference Centre for Meningococci and Haemophilus influenzae, Paris, France.

Ulrich Vogel

3 publications dans cette catégorie

Affiliations :
  • Institute for Hygiene and Microbiology, University of Würzburg, Josef-Schneider-Str. 2, 97080 Würzburg, Germany. Electronic address: vogel_u@ukw.de.

Jay Lucidarme

2 publications dans cette catégorie

Affiliations :
  • Meningococcal Reference Unit, Public Health England, Manchester Royal Infirmary, Manchester, United Kingdom.
Publications dans "Sérogroupe" :

Jae-Won Byun

2 publications dans cette catégorie

Affiliations :
  • Animal Disease Diagnostic Division, Animal and Plant Quarantine Agency, Gimcheon 39660, Korea.
Publications dans "Sérogroupe" :

Kyung-Hyo Do

2 publications dans cette catégorie

Affiliations :
  • College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Korea.
Publications dans "Sérogroupe" :

Wan-Kyu Lee

2 publications dans cette catégorie

Affiliations :
  • College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Korea.
Publications dans "Sérogroupe" :

Zhenpeng Li

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
  • Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China.

Jie Li

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
  • Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, 310003, China.
Publications dans "Sérogroupe" :

F Fani

2 publications dans cette catégorie

Affiliations :
  • Division of Microbiology, Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Publications dans "Sérogroupe" :

K Vinod Kumar

2 publications dans cette catégorie

Affiliations :
  • Indian Council of Agricultural Research-National Institute of Veterinary Epidemiology and Disease Informatics, Yelahanka, Bengaluru, Karnataka, India.

V Balamurugan

2 publications dans cette catégorie

Affiliations :
  • Indian Council of Agricultural Research-National Institute of Veterinary Epidemiology and Disease Informatics, Yelahanka, Bengaluru, Karnataka, India.

Louwrens P Snyman

2 publications dans cette catégorie

Affiliations :
  • Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Onderstepoort 0110, South Africa. lokisnyman@gmail.com.

Arie van der Ende

2 publications dans cette catégorie

Affiliations :
  • Amsterdam UMC, University of Amsterdam, Netherlands Reference Laboratory for Bacterial Meningitis, The Netherlands.
Publications dans "Sérogroupe" :

Sources (10000 au total)

A case-control study of infections caused by

Infections caused by antimicrobial-resistant bacteria are a significant cause of death worldwide, and carbapenemase-producing bacteria are the principal agents. New Delhi metallo-beta-lactamase-1 prod... A retrospective case-control study with patients hospitalized from January 2012 to February 2018 at the Hospital Civil de Guadalajara "Fray Antonio Alcalde" was designed. During this period, 139 patie... One hundred and thirty-nine case patients with a KP-NDM-1 isolate and 486 control patients were analyzed. In the case group, acute renal failure was a significant comorbidity, hospitalization days wer... In this study, the previous use of antibiotics, the use of a urinary catheter, the use of a central venous catheter, the use of mechanical ventilation, and ICU stay were shown to be predictors of infe...

Errors in Surgery: A Case Control Study.

While errors can harm patients they remain poorly studied. This study characterized errors in the care of surgical patients and examined the association of errors with morbidity and mortality.... Errors have been reported to cause <10% or >60% of adverse events. Such discordant results underscore the need for further exploration of the relationship between error and adverse events.... Patients with operations performed at a single institution and abstracted into the American College of Surgeons National Surgical Quality Improvement Program from January 1, 2018, to December 31, 2018... Of 1899 patients, 170 were defined as cases who experienced a morbidity or mortality. The majority of cases (n=93; 55%) had at least 1 error; of the 329 matched control patients, 112 had at least 1 er... Errors in surgical care were associated with postoperative morbidity. Reducing errors requires measurement of errors....

Iron status in women with infertility and controls: a case-control study.

Iron deficiency is a common problem in subfertile women. The influence of iron status on unexplained infertility is unknown.... In a case-control study, 36 women with unexplained infertility and 36 healthy non-infertile controls were included. Parameters of iron status including serum ferritin and a serum ferritin <30 µg/dL se... Women with unexplained infertility demonstrated a lower transferrin saturation (median 17.3%, IQR 12.7-25.2 versus 23.9%, IQR 15.4-31.6;... Ferritin levels <30µg/L were associated with unexplained infertility and might be screened in the future. Further studies with a focus on iron deficiency and iron treatment on women with unexplained i...

Sleeve Gastrectomy in Septuagenarians: a Case-Control Study.

There are few studies published referring to bariatric surgery in patients older than 70 years. The aim of this study is to evaluate whether there are benefits to performing sleeve gastrectomy (SG) in... Data were retrospectively collected from a Private Clinic's electronic medical records of patients undergoing SG between June 2017 and September 2020. Inclusion criteria were patients older than 70 ye... Fifty patients were included in the study. Both groups were similar regarding gender, weight, BMI, and presence of DM. The 30-day morbidity and mortality were similar between the groups. The patients ... The sleeve gastrectomy surgery performed in patients over 70 years of age is safe. The early results suggest similar benefits regarding weight loss and improvement of comorbidities to those having SG ...

Diverticulitis Familiality: A Statewide Case-Control Study.

The etiology of diverticulitis is multifactorial and poorly understood. We estimated the familiality of diverticulitis using the Utah Population Database, a statewide database linking medical records ... We identified patients with diverticulitis diagnosed between 1998 and 2018 and age- and sex-matched controls in the Utah Population Database. Risk of diverticulitis in family members of patients and c... The study population included 9,563 diverticulitis patients (with 229,647 relatives) and 10,588 controls (with 265,693 relatives). Relatives of patients were more likely to develop diverticulitis (inc... Our results indicate that the first-, second-, and third-degree relatives of diverticulitis patients are at elevated risk of developing diverticulitis. This information may aid surgeons in counseling ...

Thrombocytosis in patients with spondyloarthritis: a case-control study.

This study aimed to investigate the clinical and laboratory as well as radiological features of spondyloarthritis (SpA) patients with thrombocytosis and to explore risk factor for thrombocytosis in Sp... A total of 145 patients with SpA were included in this study, and non-thrombocytosis was identified in 76 patients while thrombocytosis was found in 69 patients, 38 out of the 69 patients received ant... The proportion of hip involvement (60.86% vs 36.84%, p = 0.004), bath ankylosing spondylitis disease activity index score (4.24 ± 0.55 vs 3.69 ± 0.67, p < 0.001), erythrocyte sedimentation rate (62.22... SpA patients with thrombocytosis have a higher proportion of hip involvement and disease activity compared to non-thrombocytosis SpA patients. The potential risk factors for thrombocytosis in SPA pati...

Vestibulodynia and the Vaginal Microbiome: A Case-Control Study.

Recent studies of the vaginal microbiome have led to a better understanding of the microbiota and interactions with the host environment, however the role of the vaginal microbiome in vestibulodynia r... This study aims to investigate and examine differences in the bacterial and fungal microbiome among patients with vestibulodynia and healthy controls.... A case-control study was conducted examining the vaginal microbiome of 29 patients with vestibulodynia and 26 controls through Stony Brook University Obstetrics and Gynecology ambulatory clinic. Exclu... Principal component analysis (PCA) and linear discriminant analysis effect size (LefSe) were used to identify differences in relative abundance of operational taxonomic units (OTUs) for the vaginal mi... Lactobacillus species were dominant amongst both cases and controls. PCA of 16S and ITS OTUs did not show significant differences in microbiome composition between vestibulodynia patients and controls... Additional studies are needed to further assess the clinical significance of these findings.... Strengths of this study include ITS amplicon sequence analysis for fungal species diversity. Limitations of this study include small sample size and lack of racial diversity.... Our study did not find significant differences in composition or diversity between the vaginal microbiomes of cases of vestibulodynia and controls; however, the data suggests differences in abundance ...

Bladder cancer with pioglitazone: A case-control study.

Varied reports suggest a contentious relationship of bladder malignancy with pioglitazone in patients with type 2 diabetes.... To study an association (prevalence and predictors) of bladder malignancy with pioglitazone therapy in Asian-Indian type 2 diabetes patients.... In this observational multicenter study, type 2 diabetic patients attending out-patient diabetes-clinic were evaluated. A detailed history of anti-diabetic medication, dose, duration, pioglitazone usa... A total of 8000 patients were screened out of which 1560 were excluded. Among 6440 included patients, 1056 (16.3%) patients were in group A and 5384 (83.6%) group B. Patients on pioglitazone were olde... Pioglitazone use in Asian-Indians is not associated with an increased bladder cancer risk. However, pioglitazone should be restricted in individuals with history of hematuria. Age more than 58 years i...

HTRA1 methylation in peripheral blood as a potential marker for the preclinical detection of stroke: a case-control study and a prospective nested case-control study.

Stroke is the leading cause of mortality in China. DNA methylation has essential roles in multiple diseases, but its association with stroke was barely studied. We hereby explored the association betw... The association was discovered in a hospital-based case-control study (cases/controls = 190:190) and further validated in a prospective nested case-control study including 139 cases who developed stro... In our study, altered HTRA1 methylation was associated with stroke at clinical and preclinical stages and thus may provide a potential biomarker in the blood for the risk evaluation and preclinical de...